Johnson & Johnson (JNJ) Sees FY13 Revs at $70.4B - $71.1B; Est. at $71.1B
Tweet
Share
E-mailGet Alerts JNJ Hot Sheet
Price: $260.35 -0.66%
Financial Fact:
Selling, marketing and administrative expenses: 4.77B
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Selling, marketing and administrative expenses: 4.77B
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Johnson & Johnson (NYSE: JNJ) sees FY13 sales of $70.4 billion to $71.1 billion. The Street is currently at about $71.1 billion.
Earlier, the
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
Earlier, the
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Globant (GLOB) Misses Q2 EPS by 10c, Offers Guidance
- Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance
- Eton Pharmaceuticals Inc. (ETON) Tops Q2 EPS by 28c, Raises Guidance
Create E-mail Alert Related Categories
Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
